COVID-19 and the cardiovascular system

• Published in: Nature reviews cardiology Vol. 17; no. 5; pp. 259 - 260
• Main Authors: Zheng, Ying-Ying, Ma, Yi-Tong, Zhang, Jin-Ying, Xie, Xiang
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.05.2020
• Subjects: Angiotensin Receptor Antagonists - therapeutic use; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Antiviral Agents - adverse effects; Betacoronavirus; Cardiotoxicity; Cardiovascular Diseases - complications; Cardiovascular Diseases - virology; Cardiovascular system; Cardiovascular System - pathology; Cardiovascular System - virology; Coronavirus Infections - complications; Coronavirus Infections - physiopathology; Coronaviruses; COVID-19; Heart - virology; Heart Diseases - virology; Humans; Hypertension - complications; Hypertension - drug therapy; Myocardium - pathology; Pandemics; Peptidyl-Dipeptidase A - metabolism; Pneumonia, Viral - complications; Pneumonia, Viral - physiopathology; Receptors, Virus - antagonists & inhibitors; Receptors, Virus - metabolism; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, while also causing acute myocardial injury and chronic damage to the cardiovascular system. Therefore, particular attention should be g...